Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
non-alcoholic fatty liver disease/protease
Odkaz je uložen do schránky
15 Výsledek
Interleukin-1 beta converting enzyme like apoptotic protease-6
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Interleukin-1.beta. converting enzyme like apoptotic protease-6
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Interleukin-1.beta. converting enzyme like apoptotic protease-6
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Interleukin-1 beta converting enzyme like apoptotic protease-7
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Apoptosis, or programmed cell death (PCD), is a genetically regulated mechanism with a central role in both metazoan development and homeostasis. (Raff, 1992; Steller, 1995). The cell death machinery is conserved throughout evolution (Vaux et al., 1994) and is composed of
Interleukin-1 .beta. converting enzyme like apoptotic protease-6
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention relates, in part, to newly identified polynucleotides and polypeptides; variants and derivatives of the polynucleotides and polypeptides; processes for making the polynucleotides and the polypeptides, and their variants and derivatives; agonists and antagonists of
Process for manufacturing soybean proteins
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a process for manufacturing soybean proteins and, more particularly, to a process for manufacturing soybean proteins particularly suitable as edible proteins.
2. Description of the Prior Art
Heretofore, processes
Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formula I,
##STR00002## wherein A, D, E, G, R.sup.10, R.sup.11, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are
Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formula I,
##STR00002## wherein A, D, E, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful for
Biaryl-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
This application claims the benefit of European Application No. EP13305402.3, filed Mar. 28, 2013, the disclosure of which is herein incorporated by reference in its entirety.
The present invention relates to compounds of the formula I,
##STR00002## wherein X, R, R1, R2, D, E.sub.1, E.sub.2,
Biaryl-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
This application claims the benefit of European Application No. EP13305401.5, filed Mar. 28, 2013, the disclosure of which is herein incorporated by reference in its entirety.
The present invention relates to compounds of the formula I,
##STR00002## wherein X, R, R1, R2, D, E.sub.1, E.sub.2,
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formula I,
##STR00002## wherein Ht, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful for the
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formula I,
##STR00002## wherein A, D, E, L, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formula I,
##STR00002## wherein A, D, E, L, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formula I,
##STR00002## wherein A, D, E, L, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are useful
Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The present invention relates to compounds of the formulae Ia and Ib,
##STR00002## wherein R1, R2, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings indicated below, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A, and are
Nejúplnější databáze léčivých bylin podložená vědou
- Funguje v 55 jazycích
- Bylinné léky podporované vědou
- Rozpoznávání bylin podle obrázku
- Interaktivní mapa GPS - označte byliny na místě (již brzy)
- Přečtěte si vědecké publikace související s vaším hledáním
- Hledejte léčivé byliny podle jejich účinků
- Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty
Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu
